292 related articles for article (PubMed ID: 33152335)
1. PDE5 inhibition improves cardiac morphology and function in SHR by reducing NHE1 activity: Repurposing Sildenafil for the treatment of hypertensive cardiac hypertrophy.
Escudero DS; Brea MS; Caldiz CI; Amarillo ME; Aranda JO; Portiansky EL; Pérez NG; Díaz RG
Eur J Pharmacol; 2021 Jan; 891():173724. PubMed ID: 33152335
[TBL] [Abstract][Full Text] [Related]
2. p38 mitogen activated protein kinase mediates cardiac Na
Díaz RG; Escudero DS; Brea MS; Morgan PE; Pérez NG
Eur J Pharmacol; 2019 Apr; 849():96-105. PubMed ID: 30721701
[TBL] [Abstract][Full Text] [Related]
3. Chronic inhibition of cGMP-specific phosphodiesterase 5 suppresses endoplasmic reticulum stress in heart failure.
Gong W; Duan Q; Cai Z; Chen C; Ni L; Yan M; Wang X; Cianflone K; Wang DW
Br J Pharmacol; 2013 Dec; 170(7):1396-409. PubMed ID: 24032459
[TBL] [Abstract][Full Text] [Related]
4. Phosphodiesterase 5 inhibition blocks pressure overload-induced cardiac hypertrophy independent of the calcineurin pathway.
Hsu S; Nagayama T; Koitabashi N; Zhang M; Zhou L; Bedja D; Gabrielson KL; Molkentin JD; Kass DA; Takimoto E
Cardiovasc Res; 2009 Feb; 81(2):301-9. PubMed ID: 19029137
[TBL] [Abstract][Full Text] [Related]
5. Prevention of PKG-1α Oxidation Suppresses Antihypertrophic/Antifibrotic Effects From PDE5 Inhibition but not sGC Stimulation.
Nakamura T; Zhu G; Ranek MJ; Kokkonen-Simon K; Zhang M; Kim GE; Tsujita K; Kass DA
Circ Heart Fail; 2018 Mar; 11(3):e004740. PubMed ID: 29545395
[TBL] [Abstract][Full Text] [Related]
6. Sildenafil reduces aortic endothelial dysfunction and structural damage in spontaneously hypertensive rats: Role of NO, NADPH and COX-1 pathways.
Leal MAS; Aires R; Pandolfi T; Marques VB; Campagnaro BP; Pereira TMC; Meyrelles SS; Campos-Toimil M; Vasquez EC
Vascul Pharmacol; 2020 Jan; 124():106601. PubMed ID: 31689530
[TBL] [Abstract][Full Text] [Related]
7. Phosphorylation of TRPC6 channels at Thr69 is required for anti-hypertrophic effects of phosphodiesterase 5 inhibition.
Nishida M; Watanabe K; Sato Y; Nakaya M; Kitajima N; Ide T; Inoue R; Kurose H
J Biol Chem; 2010 Apr; 285(17):13244-53. PubMed ID: 20177073
[TBL] [Abstract][Full Text] [Related]
8. Cyclic GMP/PKG-dependent inhibition of TRPC6 channel activity and expression negatively regulates cardiomyocyte NFAT activation Novel mechanism of cardiac stress modulation by PDE5 inhibition.
Koitabashi N; Aiba T; Hesketh GG; Rowell J; Zhang M; Takimoto E; Tomaselli GF; Kass DA
J Mol Cell Cardiol; 2010 Apr; 48(4):713-24. PubMed ID: 19961855
[TBL] [Abstract][Full Text] [Related]
9. Roles of cGMP-dependent protein kinase I (cGKI) and PDE5 in the regulation of Ang II-induced cardiac hypertrophy and fibrosis.
Patrucco E; Domes K; Sbroggió M; Blaich A; Schlossmann J; Desch M; Rybalkin SD; Beavo JA; Lukowski R; Hofmann F
Proc Natl Acad Sci U S A; 2014 Sep; 111(35):12925-9. PubMed ID: 25139994
[TBL] [Abstract][Full Text] [Related]
10. The ability of phosphodiesterase-5 inhibitors sildenafil and ordonafil to reverse L-NAME induced cardiac hypertrophy in the rabbit: possible role of calcineurin and p38.
Zeidan A; Siam A; Al Kaabba A; Mohammad M; Khatib S
Can J Physiol Pharmacol; 2012 Sep; 90(9):1247-55. PubMed ID: 22913522
[TBL] [Abstract][Full Text] [Related]
11. Regulator of G protein signaling 2 mediates cardiac compensation to pressure overload and antihypertrophic effects of PDE5 inhibition in mice.
Takimoto E; Koitabashi N; Hsu S; Ketner EA; Zhang M; Nagayama T; Bedja D; Gabrielson KL; Blanton R; Siderovski DP; Mendelsohn ME; Kass DA
J Clin Invest; 2009 Feb; 119(2):408-20. PubMed ID: 19127022
[TBL] [Abstract][Full Text] [Related]
12. Phosphodiesterase 5A inhibition decreases NHE-1 activity without altering steady state pH(i): role of phosphatases.
Díaz RG; Nolly MB; Massarutti C; Casarini MJ; Garciarena CD; Ennis IL; Cingolani HE; Pérez NG
Cell Physiol Biochem; 2010; 26(4-5):531-40. PubMed ID: 21063091
[TBL] [Abstract][Full Text] [Related]
13. Sildenafil Does Not Prevent Heart Hypertrophy and Fibrosis Induced by Cardiomyocyte Angiotensin II Type 1 Receptor Signaling.
Straubinger J; Schöttle V; Bork N; Subramanian H; Dünnes S; Russwurm M; Gawaz M; Friebe A; Nemer M; Nikolaev VO; Lukowski R
J Pharmacol Exp Ther; 2015 Sep; 354(3):406-16. PubMed ID: 26157043
[TBL] [Abstract][Full Text] [Related]
14. Empagliflozin mitigates cardiac hypertrophy through cardiac RSK/NHE-1 inhibition.
Chen S; Overberg K; Ghouse Z; Hollmann MW; Weber NC; Coronel R; Zuurbier CJ
Biomed Pharmacother; 2024 May; 174():116477. PubMed ID: 38522235
[TBL] [Abstract][Full Text] [Related]
15. Silencing of epidermal growth factor receptor reduces Na
Brea MS; Díaz RG; Escudero DS; Zavala MR; Portiansky EL; Villa-Abrille MC; Caldiz CI; Pérez NG; Morgan PE
Biochem Pharmacol; 2019 Dec; 170():113667. PubMed ID: 31622577
[TBL] [Abstract][Full Text] [Related]
16. Nitric oxide modulates cardiomyocyte pH control through a biphasic effect on sodium/hydrogen exchanger-1.
Richards MA; Simon JN; Ma R; Loonat AA; Crabtree MJ; Paterson DJ; Fahlman RP; Casadei B; Fliegel L; Swietach P
Cardiovasc Res; 2020 Oct; 116(12):1958-1971. PubMed ID: 31742355
[TBL] [Abstract][Full Text] [Related]
17. Endothelin receptor blockade combined with phosphodiesterase-5 inhibition increases right ventricular mitochondrial capacity in pulmonary arterial hypertension.
Mouchaers KT; Schalij I; Versteilen AM; Hadi AM; van Nieuw Amerongen GP; van Hinsbergh VW; Postmus PE; van der Laarse WJ; Vonk-Noordegraaf A
Am J Physiol Heart Circ Physiol; 2009 Jul; 297(1):H200-7. PubMed ID: 19395550
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of carbonic anhydrase prevents the Na(+)/H(+) exchanger 1-dependent slow force response to rat myocardial stretch.
Vargas LA; Díaz RG; Swenson ER; Pérez NG; Álvarez BV
Am J Physiol Heart Circ Physiol; 2013 Jul; 305(2):H228-37. PubMed ID: 23709596
[TBL] [Abstract][Full Text] [Related]
19. PDE5A suppression of acute beta-adrenergic activation requires modulation of myocyte beta-3 signaling coupled to PKG-mediated troponin I phosphorylation.
Lee DI; Vahebi S; Tocchetti CG; Barouch LA; Solaro RJ; Takimoto E; Kass DA
Basic Res Cardiol; 2010 May; 105(3):337-47. PubMed ID: 20107996
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of calcineurin-NFAT hypertrophy signaling by cGMP-dependent protein kinase type I in cardiac myocytes.
Fiedler B; Lohmann SM; Smolenski A; Linnemuller S; Pieske B; Schroder F; Molkentin JD; Drexler H; Wollert KC
Proc Natl Acad Sci U S A; 2002 Aug; 99(17):11363-8. PubMed ID: 12177418
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
